Clinical Trials
28 trialsDP-04
AstraZeneca
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
TRIDENT-1
Turning Point Therapeutics, Inc.
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
M.D. Anderson Cancer Center
SHERLOCK
University Health Network, Toronto
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
University of Chicago
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
CHEMOVES
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
M.D. Anderson Cancer Center
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery
Montefiore Medical Center
ReRT
The New York Proton Center
ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
Abramson Cancer Center at Penn Medicine
Feasibility Study of CBCT for IGRT in Cancer Patients
Varian, a Siemens Healthineers Company
QVA-Mod
Hospices Civils de Lyon
DETERMINE
Cancer Research UK
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface
Boehringer Ingelheim
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
I-Mab Biopharma US Limited
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
BicycleTx Limited
CAPTIV-8
British Columbia Cancer Agency
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
University of California, San Francisco
A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors
Bolt Biotherapeutics, Inc.
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
Kansas State University
PREMIER
RefleXion Medical
Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors
Second Life Therapeutics
START-001
Marengo Therapeutics, Inc.